|
|
 |
|
Viewing report
|
|
|
|
Boehringer Ingelheim GmbH - Strategy and SWOT Report
MarketLine, Nov 2011, Pages: 43
Boehringer Ingelheim GmbH - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360° view of the company.
Features:
- Detailed information on Boehringer Ingelheim GmbH required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Boehringer Ingelheim GmbH in the form of a SWOT analysis
- An in-depth view of the business model of Boehringer Ingelheim GmbH including a breakdown and examination of key business segments
- Intelligence on Boehringer Ingelheim GmbH’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Boehringer Ingelheim GmbH, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:
Boehringer Ingelheim (Boehringer or ‘the group) is a privately held company, which through its subsidiaries, is engaged in the research, development, manufacture and marketing of branded and generic prescription drugs, consumer health care products, industrial chemicals, and animal health products. The group operates in Europe, the Americas, Asia, Australia and Africa. Boehringer is headquartered in Ingelheim, Germany and employs about 42,224 people. The group recorded revenues of E14,080 million ($18,679.9 million) during the financial year ended December 2010 (FY2010), an increase of 3.1% over 2009. The operating profit of the group was E1,896 million ($2,515.4 million) in FY2010, a decrease of 15.3% over 2009. The net profit was E888 million ($1,178.1 million) in FY2010, a decrease of 49.5% over 2009.
Reasons to Purchase:
- Gain understanding of Boehringer Ingelheim GmbH and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess Boehringer Ingelheim GmbH as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on Boehringer Ingelheim GmbH’s business structure, strategy and prospects
|
|
|
|
